{"id":5659,"date":"2015-12-09T15:51:20","date_gmt":"2015-12-09T20:51:20","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/testosterone\/"},"modified":"2022-06-21T16:54:02","modified_gmt":"2022-06-21T20:54:02","slug":"testosterone","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/testosterone\/","title":{"rendered":"Testosterone"},"content":{"rendered":"<p>Le faible taux de testost\u00e9rone, famili\u00e8rement appel\u00e9 faible t, est l&#039;une des conditions m\u00e9dicales les plus fr\u00e9quemment diagnostiqu\u00e9es chez les hommes vieillissants. Cependant, en plus des inqui\u00e9tudes quant \u00e0 savoir si les personnes diagnostiqu\u00e9es avec la maladie en souffrent r\u00e9ellement (ou ressentent simplement des sympt\u00f4mes normaux associ\u00e9s \u00e0 l&#039;\u00e2ge), les m\u00e9dicaments fabriqu\u00e9s pour traiter le faible t peuvent \u00eatre dangereux. Si vous avez re\u00e7u un diagnostic de faible taux de testost\u00e9rone et prescrit des m\u00e9dicaments \u00e0 faible t,<em> ou<\/em> si vous avez pris des injections ou des pilules de testost\u00e9rone pour traiter un retard de pubert\u00e9, une impuissance ou un cancer du sein, voici ce que vous devez savoir :<\/p>\n<p>&nbsp;<\/p>\n<h3>Les risques des m\u00e9dicaments \u00e0 base de testost\u00e9rone<\/h3>\n<p>Les hommes se voient souvent prescrire des m\u00e9dicaments \u00e0 faible t pour traiter des probl\u00e8mes de \u00abmode de vie\u00bb plut\u00f4t que des probl\u00e8mes m\u00e9dicaux. Et le <a href=\"http:\/\/www.wsj.com\/articles\/fda-panel-recommends-more-study-on-testosterone-drugs-for-low-t-use-1410994105\" target=\"_blank\" rel=\"noopener\">les risques de prendre des m\u00e9dicaments \u00e0 faible t sont nombreux<\/a> \u2013 des \u00e9tudes indiquent que la prise d&#039;une ordonnance \u00e0 faible taux de testost\u00e9rone peut augmenter le risque pour un homme de :<\/p>\n<ul>\n<li>Crise cardiaque;<\/li>\n<li>Accident vasculaire c\u00e9r\u00e9bral; et<\/li>\n<li>D\u00e9c\u00e8s.<\/li>\n<\/ul>\n<p>In fact, in March of 2015, the U.S. Food &amp; Drug Administration (FDA) issued a safety announcement cautioning against the use of low-t drugs for aging, and requiring low-t drug manufacturers to change labels on their products to include risks of heart attack and stroke.<\/p>\n<p>Testosterone injections may also be given to women who are suffering from breast cancer, or to men or boys who are suffering from symptoms caused by a lack of the hormone (delayed puberty, erectile dysfunction, etc.) However, testosterone injections, pellets, and pills have been associated with emotional changes, changes in sexual function, changes in sleep patterns, gynecomastia, and more.<\/p>\n<p>&nbsp;<\/p>\n<h3>Que dois-je savoir sur le d\u00e9p\u00f4t d&#039;une plainte\u00a0?<\/h3>\n<p><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.SearchAction&amp;SearchType=BasicSearch&amp;searchTerm=testosterone&amp;Search_Button=Submit\" target=\"_blank\" rel=\"noopener\">M\u00e9dicaments \u00e0 faible t et th\u00e9rapie \u00e0 la testost\u00e9rone<\/a> can be very dangerous for a patient. If you have suffered harm as a result of either, you may have the right to civil action. To help you understand whether or not you are entitled to file a suit and reclaim damages, and how to file a lawsuit directly against a dangerous drug\u2019s manufacturer, you need an attorney.<\/p>\n<p>At Napoli Shkolnik, PLLC, our experienced <a href=\"\/fr\/domaines-de-pratique-2\/contentieux-pharmaceutique\/\">contentieux pharmaceutique<\/a> l&#039;\u00e9quipe est pr\u00eate \u00e0 se battre pour vous. Pour en savoir plus, planifiez une consultation avec nous pour discuter de votre cas aujourd&#039;hui.<\/p>","protected":false},"excerpt":{"rendered":"<p>Low testosterone, colloquially called low-t, is one of the most commonly diagnosed medical conditions amongst aging men. However, in addition to concerns about whether those who are diagnosed with the&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":194,"template":"","practiceareas_category":[743],"class_list":["post-5659","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5659\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5659"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}